ABCG1 and metabolic syndrome: Hypermethylation of ABCG1 results in a decrease in gene expression, which is associated with cholesterol metabolism disorders, impaired insulin secretion, and accelerated foam cell formation, and may contribute to type 2 diabetes mellitus, metabolic syndrome, and atherosclerosis CVDs [32–34].